Positive Clinical Data Supports Development of Single, Intranasal, Adjuvant-Free COVID-19 Vaccine Candidate
Meissa Vaccines (South San Francisco, CA, USA) has initiated preclinical studies and manufacturing and completed a pre-IND meeting with the US Food and Drug Administration (FDA) for the development of MV-014-210, a live attenuated vaccine (LAV) candidate to induce immunity and protect against SARS-CoV-2. More...01 Jul 2020
New Images Show for First Time How SARS-CoV-2 Dramatically Rewires Important Cell Programming
A study of proteins in human cells to determine mechanisms by which SARS-CoV-2 shifts cellular activity in infected cells has found for the first time that cells infected with the virus exhibit filopodia, stringy arm-like extensions, which may explain rapid viral spread throughout the body. More...30 Jun 2020
Altimmune Receives Funding for Trial of Intranasal Candidate for Treatment of Outpatients with Early COVID-19
Altimmune, Inc. (Gaithersburg, MD, USA) has been was awarded USD 4.7 million by the US Army Medical Research & Development Command (USAMRDC) to fund its Phase 1/2 clinical trial of T-COVID, an investigational intranasal immune modulator for the treatment of outpatients with early COVID-19. More...30 Jun 2020
New Online Tool Highlights Potential Future COVID-19 Virus Hotspots
A new online tool can identify potential COVID-19 hotspots by highlighting which regions have the most at-risk factors and can also supplement test-and-trace technology in highlighting potential future infection spikes. More...30 Jun 2020
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Standing Sling
Sara Flex
New
Transcatheter Heart Valve
SAPIEN 3 Ultra
In Other News
Beckman Coulter's SARS-CoV-2 IgG Antibody Test Granted FDA Emergency Use Authorization
Volunteers in Brazil Receive Oxford COVID-19 Vaccine in Latin America’s First Phase 3 Clinical Trial
Roche Advances Personalized Healthcare with Development of Image Analysis Algorithms Using Artificial Intelligence
AstraZeneca's COVID-19 Vaccine Is World’s Leading Candidate and May Deliver Results Earlier, Says WHO
COVID-19 Patients in ICU 10 Times More Likely to Experience Heart Rhythm Disorders, Finds Study
Vaxart’s Oral COVID-19 Vaccine Selected for US Operation Warp Speed Program
New One-Piece Injection-Molded COVID-19 Swab to Enable Expanded Testing
Shortage of Glass Vials Could Delay Rollout of COVID-19 Vaccine
Novel S-Layer Intranasal and Oral COVID-19 Vaccine Could Decrease Severity of SARS-CoV-2 Infection
COVID-19 Patients Develop Fatal Blood Clots Due to High Alpha Defensin Protein Levels, Find Researchers
Reusable Antimicrobial Mask Neutralizes Close to 99% of Coronavirus Even After 100 Washings
Coronavirus Mutating to Become Less Vicious and Could Die Out Without Vaccine, Claims Expert
Electric Anti-Viral Face Mask Eradicates Coronavirus Upon Contact
Anti-Androgen Drugs for Male Baldness Could Provide Possible Breakthrough Treatment for COVID-19
Experts Identify Steps to Expand and Improve Antibody Tests in COVID-19 Response
Moderna Collaborates with Catalent for Fill-Finish Manufacturing of mRNA-Based COVID-19 Vaccine Candidate
World's First Inactivated COVID-19 Vaccine Produces Antibodies in All Participants in Clinical Trial
New Platform to Accelerate COVID-19 Tests into Real-World Use
Oxford’s COVID-19 Vaccine Begins Testing in Human Volunteers
Biohit's SARS-CoV-2 IgM/IgG Antibody Test Kit Granted FDA Emergency Use Authorization
ERBA Mannheim Launches CE Marked COVID-19 IgM Antibody ELISA Kit
N95 Face Masks Get Pathogen Killing Technology with Addition of New UVC Medical Device
World’s First High-Throughput, Multi-Antigen COVID-19 Biochip Test Launched
